Re: Tom J.H. Arends, Ofer Nativ, Massimo Maffezzini, et al. Results of a Randomised Controlled Trial Comparing Intravesical Chemohyperthermia with Mitomycin C Versus Bacillus Calmette-Guérin for Adjuvant Treatment of Patients with Intermediate- and High-risk Non-Muscle-invasive Bladder Cancer. Eur Urol 2016;69:1046-52

Affiliations

¹ Department of Urology, Medical University of Warsaw, Warsaw, Poland. Electronic address: slawomir.poletajew@wum.edu.pl.
² Department of Urology, Medical University of Warsaw, Warsaw, Poland.
³ Department of Urology, Fundacio Puigvert, Universitat Autonoma de Barcelona, Barcelona, Spain.

Comment

Sławomir Poletajew et al. Eur Urol. 2017 Jan.

. 2017 Jan;71(1):e29-e30.

doi: 10.1016/j.eururo.2016.06.042. Epub 2016 Jul 11.

¹ Department of Urology, Medical University of Warsaw, Warsaw, Poland. Electronic address: slawomir.poletajew@wum.edu.pl.
² Department of Urology, Medical University of Warsaw, Warsaw, Poland.
³ Department of Urology, Fundacio Puigvert, Universitat Autonoma de Barcelona, Barcelona, Spain.

No abstract available

Comment in

Results of a Randomised Controlled Trial Comparing Intravesical Chemohyperthermia with Mitomycin C Versus Bacillus Calmette-Guérin for Adjuvant Treatment of Patients with Intermediate- and High-risk Non-Muscle-invasive Bladder Cancer.
Arends TJ, Nativ O, Maffezzini M, de Cobelli O, Canepa G, Verweij F, Moskovitz B, van der Heijden AG, Witjes JA. Arends TJ, et al. Eur Urol. 2016 Jun;69(6):1046-52. doi: 10.1016/j.eururo.2016.01.006. Epub 2016 Jan 20. Eur Urol. 2016. PMID: 26803476 Clinical Trial.